Nader in a previous video was talking that they we

Quote:

---

Nader in a previous video was talking that they were working on a deal for cancer so it could be that or they would go with another deal with Vyera. I am sure Vyera would be more then happy to.

---

For practical purposes I do not think this is a good idea. In order to de-risk the commercialization we should find, either a partner, or another commercialization company for Oncology.

My reasoning is simply a matter of size and safety. Oncology is a completely different ball game and it would work in our advantage to have two companies commercializing rather than one (more resources, more publicity, more sales people, more competition). Apart from that, if Vyera or the "other" don't perform as expected is less detrimental to CYDY's bottom-line.

The way it is now, Vyera would not be able to pay the up-front amounts that would be required for a good Oncology deal (remember BC market is $18B/year).

I say: let's go with somebody else to de-risk !!!